Express News | Omeros Corp - FDA Requests Additional Sensitivity Analyses for Sap

ReutersNov 21 09:15 ET

Express News | Omeros Corp - Independent Expert Statistical Group to Conduct Analyses

ReutersNov 21 09:15 ET

Express News | Omeros Corp - Receives FDA Response on Revised Sap for Narsoplimab Bla

ReutersNov 21 09:15 ET

Express News | Omeros Corporation Provides Update on Progress Toward Bla Resubmission

ReutersNov 21 09:15 ET

While Institutions Invested in Omeros Corporation (NASDAQ:OMER) Benefited From Last Week's 54% Gain, Retail Investors Stood to Gain the Most

Simply Wall StNov 15 05:13 ET

Omeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab Application

WSJNov 14 13:33 ET